Cargando…

Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections

Objective: To analyze the availability and access to the hospital for the patients with intra-abdominal infections (IAIs) by Escherichia coli (E. coli) as a result of the coronavirus disease 2019 (COVID-19) pandemic and the impact of these changes in the diagnosis and their effects on the death of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gálvez-Benítez, Lydia, Rodríguez-Villodres, Ángel, Álvarez-Marín, Rocío, Jiménez-Rodríguez, Rosa, Lepe-Jiménez, José Antonio, Pachón, Jerónimo, Smani, Younes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563694/
https://www.ncbi.nlm.nih.gov/pubmed/34746164
http://dx.doi.org/10.3389/fmed.2021.687415
_version_ 1784593459408011264
author Gálvez-Benítez, Lydia
Rodríguez-Villodres, Ángel
Álvarez-Marín, Rocío
Jiménez-Rodríguez, Rosa
Lepe-Jiménez, José Antonio
Pachón, Jerónimo
Smani, Younes
author_facet Gálvez-Benítez, Lydia
Rodríguez-Villodres, Ángel
Álvarez-Marín, Rocío
Jiménez-Rodríguez, Rosa
Lepe-Jiménez, José Antonio
Pachón, Jerónimo
Smani, Younes
author_sort Gálvez-Benítez, Lydia
collection PubMed
description Objective: To analyze the availability and access to the hospital for the patients with intra-abdominal infections (IAIs) by Escherichia coli (E. coli) as a result of the coronavirus disease 2019 (COVID-19) pandemic and the impact of these changes in the diagnosis and their effects on the death of these patients. Methods: Two prospective observational cohorts of the patients with IAI by E. coli were conducted in 2016 (the pre-COVID-19, n = 108) and in 2020 (during the COVID-19, n = 96) at the University Hospital of Seville, Spain. The demographic and clinical variables of the patients were collected and analyzed. The patients were followed-up for 120 days, until the hospital discharge or death. The bivariate and multivariate analyses were performed. Results: Both the cohorts were homogeneous according to age, sex, emergency surgery cause, immunosuppression, neutropenia, acquisition type, and previous intervention. The patients attended during the COVID-19 had significantly higher Charlson comorbidity index and the more McCabe score, required more emergency surgery, had more severe infections with the higher rates of septic shock and sepsis, and the presence of additional care support such as a nasogastric tube. They were diagnosed later; the time intervals between the symptoms onset (SO) to the first medical contact or surgical intervention (SI) and between the first medical contact to the admission or SI were significantly higher. The death rates during the COVID-19 and the pre-COVID-19 were 16.7 and 6.5%, respectively (p = 0.02). Finally, the multivariate analysis in both the cohorts together identified the patients diagnosed during the COVID-19, the longer period from SO to SI, septic shock, and the Charlson comorbidity index as the independent factors associated with death. Conclusion: This study showed the impact of the COVID-19 pandemic on the clinical outcome and death due to IAI with an extension of the time between SO and SI.
format Online
Article
Text
id pubmed-8563694
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85636942021-11-04 Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections Gálvez-Benítez, Lydia Rodríguez-Villodres, Ángel Álvarez-Marín, Rocío Jiménez-Rodríguez, Rosa Lepe-Jiménez, José Antonio Pachón, Jerónimo Smani, Younes Front Med (Lausanne) Medicine Objective: To analyze the availability and access to the hospital for the patients with intra-abdominal infections (IAIs) by Escherichia coli (E. coli) as a result of the coronavirus disease 2019 (COVID-19) pandemic and the impact of these changes in the diagnosis and their effects on the death of these patients. Methods: Two prospective observational cohorts of the patients with IAI by E. coli were conducted in 2016 (the pre-COVID-19, n = 108) and in 2020 (during the COVID-19, n = 96) at the University Hospital of Seville, Spain. The demographic and clinical variables of the patients were collected and analyzed. The patients were followed-up for 120 days, until the hospital discharge or death. The bivariate and multivariate analyses were performed. Results: Both the cohorts were homogeneous according to age, sex, emergency surgery cause, immunosuppression, neutropenia, acquisition type, and previous intervention. The patients attended during the COVID-19 had significantly higher Charlson comorbidity index and the more McCabe score, required more emergency surgery, had more severe infections with the higher rates of septic shock and sepsis, and the presence of additional care support such as a nasogastric tube. They were diagnosed later; the time intervals between the symptoms onset (SO) to the first medical contact or surgical intervention (SI) and between the first medical contact to the admission or SI were significantly higher. The death rates during the COVID-19 and the pre-COVID-19 were 16.7 and 6.5%, respectively (p = 0.02). Finally, the multivariate analysis in both the cohorts together identified the patients diagnosed during the COVID-19, the longer period from SO to SI, septic shock, and the Charlson comorbidity index as the independent factors associated with death. Conclusion: This study showed the impact of the COVID-19 pandemic on the clinical outcome and death due to IAI with an extension of the time between SO and SI. Frontiers Media S.A. 2021-10-20 /pmc/articles/PMC8563694/ /pubmed/34746164 http://dx.doi.org/10.3389/fmed.2021.687415 Text en Copyright © 2021 Gálvez-Benítez, Rodríguez-Villodres, Álvarez-Marín, Jiménez-Rodríguez, Lepe-Jiménez, Pachón and Smani. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Gálvez-Benítez, Lydia
Rodríguez-Villodres, Ángel
Álvarez-Marín, Rocío
Jiménez-Rodríguez, Rosa
Lepe-Jiménez, José Antonio
Pachón, Jerónimo
Smani, Younes
Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
title Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
title_full Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
title_fullStr Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
title_full_unstemmed Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
title_short Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
title_sort impact of the covid-19 pandemic on survival in the patients with the intra-abdominal infections
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563694/
https://www.ncbi.nlm.nih.gov/pubmed/34746164
http://dx.doi.org/10.3389/fmed.2021.687415
work_keys_str_mv AT galvezbenitezlydia impactofthecovid19pandemiconsurvivalinthepatientswiththeintraabdominalinfections
AT rodriguezvillodresangel impactofthecovid19pandemiconsurvivalinthepatientswiththeintraabdominalinfections
AT alvarezmarinrocio impactofthecovid19pandemiconsurvivalinthepatientswiththeintraabdominalinfections
AT jimenezrodriguezrosa impactofthecovid19pandemiconsurvivalinthepatientswiththeintraabdominalinfections
AT lepejimenezjoseantonio impactofthecovid19pandemiconsurvivalinthepatientswiththeintraabdominalinfections
AT pachonjeronimo impactofthecovid19pandemiconsurvivalinthepatientswiththeintraabdominalinfections
AT smaniyounes impactofthecovid19pandemiconsurvivalinthepatientswiththeintraabdominalinfections